Barclays Initiates Coverage On Squarespace with Equal-Weight Rating, Announces Price Target of $70
Barclays initiates coverage on Squarespace (NYSE:SQSP) with a Equal-Weight rating and announces Price Target of $70.
B of A Securities Initiates Coverage On DLocal with Buy Rating, Announces Price Target of $55
B of A Securities initiates coverage on DLocal (NASDAQ:DLO) with a Buy rating and announces Price Target of $55.
Roth Capital Initiates Coverage On Panbela Therapeutics with Buy Rating, Announces Price Target of $10
Roth Capital analyst Tony Butler initiates coverage on Panbela Therapeutics (NASDAQ:PBLA) with a Buy rating and announces Price Target of $10.
JMP Securities Initiates Coverage On Perella Weinberg Partners – Class A Common Stock with Market Outperform Rating, Announces Price Target of $17
JMP Securities analyst Devin Ryan initiates coverage on Perella Weinberg Partners - Class A Common Stock (NASDAQ:PWP) with a Market Outperform rating and announces Price Target of $17.
Truist Securities Initiates Coverage On Albany Intl with Hold Rating
Truist Securities analyst Michael Ciarmoli initiates coverage on Albany Intl (NYSE:AIN) with a Hold rating.
Truist Securities Initiates Coverage On Paya Holdings with Buy Rating, Announces Price Target of $15
Truist Securities analyst Andrew Jeffrey initiates coverage on Paya Holdings (NASDAQ:PAYA) with a Buy rating and announces Price Target of $15.
Redburn Partners Initiates Coverage On Salesforce.com with Buy Rating
Redburn Partners analyst Neil Steer initiates coverage on Salesforce.com (NYSE:CRM) with a Buy rating.
Needham Initiates Coverage On Thryv Holdings with Buy Rating, Announces Price Target of $42
Needham analyst Scott Berg initiates coverage on Thryv Holdings (NASDAQ:THRY) with a Buy rating and announces Price Target of $42.
Goldman Sachs Initiates Coverage On DLocal with Neutral Rating, Announces Price Target of $30
Goldman Sachs analyst Tito Labarta initiates coverage on DLocal (NASDAQ:DLO) with a Neutral rating and announces Price Target of $30.
Guggenheim Initiates Coverage On Repare Therapeutics with Buy Rating, Announces Price Target of $46
Guggenheim analyst Charles Zhou initiates coverage on Repare Therapeutics (NASDAQ:RPTX) with a Buy rating and announces Price Target of $46.